UMass disbands its entering biomed graduate class over Trump funding chaos
Briefly

Several prestigious universities are gearing up for pronounced declines in support, leading to significant reductions in graduate admissions and research capabilities. Duke University plans a 23% cut in biomedical PhD admissions, while Vanderbilt and other institutions are following suit. Faculty at the University of Pennsylvania had to rescind admission offers due to these financial strains, which Beth Sullivan noted threatens the future of medical research. Experts warn that fewer researchers mean diminished scientific progress, innovation, and public health advancements, significantly impacting the broader economy.
Our next generation of researchers are now poised on the edge of this cliff, not knowing if there's going to be a bridge that gets them to the other side.
This is a severe blow to science and the training of the next generation of scientists, leading to less science and innovation that drive societal progress.
Read at Ars Technica
[
|
]